H.R. 1750 · 119th Congress
HEARD Act of 2025
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Not yet voted on. This bill is still a proposal: it hasn't reached a floor vote, and its text can change in committee or on the floor before any vote.
5 cosponsors · 5 D
0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Health Equity and Rare Disease Act of 2025 or the HEARD Act of 2025
What it does: CRS summary · Introduced in House · Feb 27, 2025
Health Equity and Rare Disease Act of 2025 or the HEARD Act of 2025
This bill establishes Department of Health and Human Services (HHS) grants and other initiatives to address rare diseases or conditions (e.g., those affecting less than 200,000 people in the United States) in racial and ethnic minority populations.
For example, to advance such purposes, the bill establishes within HHS
- grants to public and private nonprofit entities for data collection and public outreach,
- grants to health professions schools to improve health care and minority representation in research regarding rare diseases and conditions,
- grants to tribal epidemiology centers and tribal and urban Indian health centers for research regarding rare diseases and conditions in tribal communities,
- scholarships and educational loan repayment for medical school students who agree to work as health care professionals serving populations with rare diseases or conditions,
- initiatives to coordinate research and other activities across the National Institutes of Health, and
- public health awareness and education campaigns.
Also, the bill requires HHS to submit various reports to Congress on topics including (1) the federal government’s research and public health activities regarding rare diseases or conditions in minority populations, (2) regulatory barriers to treating rare diseases in Medicare beneficiaries of color, and (3) strategies for research and development of treatments for rare diseases or conditions that disproportionately impact minority populations.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: HEARD Act of 2025
Also known as: Health Equity and Rare Disease Act of 2025
Latest action (Feb 27, 2025): Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Policy area: Health · Origin: House · Introduced: Feb 27, 2025
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.